An interventional study of Alcon SN60WF and Hoya Vivinex in Age Related Cataracts, sponsored by Medical University of Vienna. Completed. Open to participants aged 50 Years to 100 Years. Per ClinicalTrials.gov, last updated 2019-12-12.
Sponsored by Medical University of Vienna · Not applicable, Interventional, and Diagnostic
On the day of surgery, the first eye to be operated is randomised to receive a Vivinex , HOYA Surgical Optics GmbH or an SN60WF, Alcon, Fort Worth, Texas. The second eye to be operated receives the other IOL type.
A complete biomicroscopic examination, visual acuity testing using autorefractometer, contrast sensitivity testing, and standardised retroillumination photography for PCO evaluation, will be performed 6 month (30-60 days), 1.5 years (± 3 months) and 3 (± 3 months) years postoperatively.
1,701 studies on the registry are indexed under Cataract; 230 are open to participants now.
This study's enrollment of 80 is close to the median of 80 across 1,155 interventional studies indexed under Cataract.
Browse Cataract studies →Medical University of Vienna is the lead sponsor of 1,076 studies on the registry; 177 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Implantation of an intraocular lens Alcon SN60WF
Device: Alcon SN60WF
Implantation of an intraocular lens Hoya Vivinex
Device: Hoya Vivinex
Implantation of an intraocular lens Alcon SN60WF
Implantation of an intraocular lens Hoya Vivinex
PCO score
subjectively and objectively graded: 0-10 (0= no PCO, 10= maximum PCO)
Time frame: 3 years
Visual Acuity
UCDVA(uncorrected distance visual acuity), BCDVA (best corrected distance visual acuity)
Time frame: 3 years
Fibrosis
grade of fibrosis assessed subjectively at the slitlamp (grade 0=no fibrosis, grade 3=maximum fibrosis)
Time frame: 3 years
Subjective glistening score
neg, \<10, 10-20, 20-30, 30-40, \>40 uniform or localized
Time frame: 3 years
YAG capsulotomy rate
described subjectively at the slitlamp: was a YAG capsulotomy performed yes/no
Time frame: 3 years
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Dec 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Medical University of Vienna